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Prior to disease onset, chronic stress or increased exposure 
to endogenous or exogenous corticosteroids can precipitate 
 physiological and psychological changes that increase risk for chronic 
disease; the effects of stress have been particularly well-documented 
in the context of contributing to the development of cardiovascular 
and cerebrovascular disease. Several of the important endogenous 
risk factors for human vascular disease can be modiﬁ  ed by stress or 
are associated with HPA axis dysregulation, including high blood 
pressure, elevated serum cholesterol, glucose intolerance, high body 
mass index, and inﬂ  ammation. For example, systemic hypertension 
is associated with blunted morning cortisol and impaired negative 
feedback of the HPA axis (Wirtz et al., 2007), as well as increased 
cortisol responses to stress (Nyklicek et al., 2005). Serum cholesterol 
is elevated immediately following an acute laboratory stressor and 
remains elevated among those experiencing chronic stress (Stoney 
et al., 1999a,b); in turn, elevated cholesterol can facilitate athero-
sclerosis (reviewed in Insull, 2009). Likewise, extended release of 
HPA axis hormones that are responsible for increasing blood glu-
cose to meet energy demands during an acute stressor, can result 
in the development of myopathy (Tomas et al., 1979; Mitsui et al., 
2002) and steroid diabetes (Homo-Delarche et al., 1991) over time. 
Exposure to stress also can alter eating habits (Zellner et al., 2006, 
2007; Adam and Epel, 2007) and the distribution of body fat; spe-
ciﬁ  cally, increased corticosteroid and psychological responses to 
THE LINK BETWEEN THE HYPOTHALAMIC-PITUITARY-
ADRENAL AXIS AND CHRONIC DISEASE
Activation of the hypothalamic-pituitary-adrenal (HPA) axis 
  following exposure to a stressor is part of an adaptive response 
that enables an organism to respond appropriately to changes in 
the environment (McEwen, 2000). The hormonal cascade initiated 
by stress involves the release of corticotropin-  releasing hormone 
(CRH) from the paraventricular nucleus of the hypothalamus into 
hypothalamo-hypophyseal portal blood vessels, through which 
it travels to the anterior pituitary gland, where it stimulates the 
release of adrenocorticotrophic hormone (ACTH). ACTH then 
enters the general circulation, and stimulates the adrenal cortex to 
produce and secrete glucocorticoids (GCs). There are two main, 
  structurally similar, GCs among mammals: corticosterone (pre-
dominant in most rodents) and cortisol ( predominant in humans 
and most other mammals). Norepinephrine and epinephrine, two 
additional hormones important in coordinating the physiologi-
cal and behavioral responses to stress, are released by the adrenal 
medulla within seconds of exposure to stress. Although the physi-
ological necessity of GC and catecholamine secretion is apparent 
when responding to an acute stressor, repeated and prolonged 
  exposure to these hormones over the course of a life-time can 
increase vulnerability to a wide array of physical and  psychological 
pathologies (Korte et al., 2005; McEwen, 2008).
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Chronic stress is capable of exacerbating each major, modiﬁ  able, endogenous risk factor for 
cerebrovascular and cardiovascular disease. Indeed, exposure to stress can increase both the 
incidence and severity of stroke, presumably through activation of the hypothalamic-pituitary-adrenal 
(HPA) axis. Now that characterization of the mechanisms underlying epigenetic programming of 
the HPA axis is well underway, there has been renewed interest in examining the role of early 
environment on the evolution of health conditions across the entire lifespan. Indeed, neonatal 
manipulations in rodents that reduce stress responsivity, and subsequent life-time exposure 
to glucocorticoids, are associated with a reduction in the development of neuroendocrine, 
neuroanatomical, and cognitive dysfunctions that typically progress with age. Although improved 
day to day regulation of the HPA axis also may be accompanied by a decrease in stroke risk, 
evidence from rodent studies suggest that an associated cost could be increased susceptibility 
to inﬂ  ammation and neuronal death in the event that a stroke does occur and the individual is 
exposed to persistently elevated corticosteroids. Given its importance in regulation of health 
and disease states, any long-term modulation of the HPA axis is likely to be associated with both 
beneﬁ  ts and potential risks. The goals of this review article are to examine (1) the clinical and 
experimental data suggesting that neonatal experiences can shape HPA axis regulation, (2) the 
inﬂ  uence of stress and the HPA axis on stroke incidence and severity, and (3) the potential for 
neonatal programming of the HPA axis to impact adult cerebrovascular health.
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for  normal fetal  development, but it also increases vulnerability of 
the fetus to   elevated circulating GCs originating from the moth-
er’s   adrenal gland. The fetus is partially protected by placental 
11beta-  hydroxysteroid dehydrogenase, which enables GCs from 
the mother to be converted into an inactive form when crossing the 
placenta (Edwards et al., 1993; Benediktsson et al., 1997; reviewed 
in O’Donnell et al., 2009); indeed a negative correlation between 
cortisol concentrations in umbilical cord and placental 11beta-
HSD activity has been observed in full-term human pregnancies 
(Mericq et al., 2009). Furthermore, mutations in the human 11beta-
hydroxysteroid dehydrogenase gene are associated with low birth 
weight (Mune et al., 1995), which is presumably related to increased 
in utero exposure to GCs (Seckl and Holmes, 2007). However, even 
in the absence of such a mutation, a precipitous rise in maternal glu-
cocorticoid concentrations in response to extreme stress or admin-
istration of exogenous hormones, could overwhelm the placental 
11beta-hydroxysteroid dehydrogenase, and increase fetal exposure 
to glucorticoids, which could conceivably alter the structure and 
function of endocrine and insulin-sensitive target tissues in the 
fetus (Holness et al., 2000). For example, there is a stronger posi-
tive correlation between maternal and amniotic cortisol concentra-
tions among pregnant women who report elevated anxiety during 
pregnancy than those who are not anxious (Glover et al., 2009). 
Indeed, there are a plethora of studies in humans linking perinatal 
measures, such as birth weight, with adult metabolic disorders and 
vascular disease; however, much of the evidence supporting a causal 
relationship between early exposure to GCs and health measures in 
adulthood have been gleaned from experimental studies utilizing 
non-human primates and rodents. These studies also aid in identi-
fying and conﬁ  rming underlying mechanisms, such as the effects of 
maternal stress on placental 11beta-hydroxysteroid dehydrogenase 
type 2 expression and activity, organ weights, and the expression 
of a variety of genes related to HPA axis function and metabolism 
in rats (Mairesse et al., 2007). Thus, there are several human and 
experimental studies supporting the conclusion that the relatively 
protective environment of the fetus can be compromised by stress, 
which in turn can alter fetal development, and cause potental long-
term health consequences.
To explain such consequences of fetal environment on long-term 
health, the fetal programming hypothesis was developed. The fetal 
programming hypothesis proposes that the physiological, neuroen-
docrine, or metabolic adaptations that enable the fetus to ade-
quately respond to changes in the early life environment can result 
in semi-permanent phenotypic changes in the fetus (reviewed in 
Barker, 1998). The altered programming of the developmental pat-
tern of proliferation and differentiation events within key tissue and 
organ systems can permanently alter the set points in the metabolic, 
  cardiovascular, and immune systems of the individual (Barker, 
1997, 2002; Coe et al., 1999; Fagoaga and Nehlsen-Cannarella, 
2002; Louey and Thornburg, 2005; Phillips, 2006). One of the 
primary areas of interest in fetal programming research has been 
the correlation between low birth weight and adult cardiovascular 
disease (Seckl, 2001; Barker et al., 2009). In the past, the majority of 
investigations of the long-term consequences of low birth weight 
have focused on fetal nutrition. It was suggested that malnourish-
ment resulted in fetal metabolic adaptations, such as the develop-
ment of tissue insulin resistance, that reduce glucose metabolism 
stress are associated with increased abdominal accumulation of fat 
(Epel et al., 2000), which in turn is associated with elevated cardio-
vascular and cerebrovascular risk (Mathieu et al., 2009). Stress also 
can affect vascular health via alterations in the immune system. For 
example, chronic care-giver stress is associated with overproduction 
of serum IL-6 (Kiecolt-Glaser et al., 2003), a pro-inﬂ  ammatory 
cytokine that is associated with increased risk for heart disease and 
stroke (Cesari et al., 2003; Kaplan et al., 2008b). Furthermore, in 
correlational analyses, established risk factors for cardiovascular 
disease and stroke typically form anthropometric, metabolic, and 
haemodynamic clusters that are not intercorrelated (Rosmond 
and Bjorntorp, 2000). However, when subjects exhibiting signs 
of HPA axis dysregulation are analyzed separately, these clusters 
become strongly intercorrelated, such that one cluster, including 
all anthropometric, metabolic and haemodynamic factors (except 
high density lipoprotein), is apparent rather than three separate 
clusters (Rosmond and Bjorntorp, 2000). Thus, HPA axis function 
may have an intervening inﬂ  uence on nearly all other major risk fac-
tors for vascular disease in humans. This relationship between HPA 
axis function and disease factors provides a mechanism through 
which genetic inﬂ  uences (for example, see Rosmond et al., 2000; 
Koeijvoets et al., 2008), aging (Ferrari and Magri, 2008), and life-
time exposure to stress (Korte et al., 2005) can modify vulnerability 
to vascular disease.
INDIVIDUAL DIFFERENCES IN HPA AXIS FUNCTION AS A 
SOURCE OF VULNERABILITY TO VASCULAR DISEASE
Individual differences in stress responsivity play an important role 
in determining both the acute and cumulative effects of GC expo-
sure over the course of a life-time. There are signiﬁ  cant differences 
in how individuals perceive and interpret stressors, and the encod-
ing of memories of past stressful events inﬂ  uences one’s response 
to future stressors (Buchanan and Lovallo, 2001; Marti et al., 2001; 
Wolf, 2003). Genetic factors also can contribute to individual dif-
ferences in HPA function and stress responsivity (Kuningas et al., 
2007; Ising et al., 2008; Peeters et al., 2008; Raef et al., 2008; Duan 
et al., 2009). Recognizing the potential for an interaction between 
glucocorticoid gene polymorphisms and environment in inﬂ  uenc-
ing physiological and behavioral phenotypes is also important (Bet 
et al., 2008). However, maternal inﬂ  uences during the prenatal and 
early post-natal developmental periods may be another important 
source of variance in HPA axis function, allostatic load, and the 
onset of psychopathology and age-related disease (Matthews, 2000; 
Barrington, 2001; McEwen, 2002; Gluckman et al., 2005; Patin et al., 
2005), including stroke and heart disease (Barker, 1997; Lamireau 
et al., 2002; Sinclair et al., 2007).
The quality of the uterine environment and maternal-infant 
interactions in early life varies widely among humans. A plethora of 
studies over the past two decades have suggested that these factors 
can contribute to early programming of the HPA axis (reviewed 
in  Barker, 1997; Seckl, 2000; Mesquita et  al., 2009). Although 
there is some evidence that the human fetal adrenal cortex is 
capable of synthesizing cortisol as early as the ﬁ  rst trimester of 
gestation (Goto et al., 2006), expression of intracellular glucocor-
ticoid receptors does not become apparent in the hippocampus 
and other major systems and tissues until mid to late gestation 
(Noorlander et al., 2006). The onset of GR expression is  important Frontiers in Behavioral Neuroscience  www.frontiersin.org  December 2009  | Volume 3  |  Article 54  |  3
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factors in these studies, they do suggest that stress exposure during 
early development can have long-lasting effects on the psychiat-
ric and physiological health of the offspring. To address the issue 
of inherited versus pre- and post-natal environmental factors on 
adverse health and behavioral outcomes in the offspring, a clinical 
study observed children born to related or unrelated mothers as a 
result of in vitro fertilization. The conclusion was that regardless of 
genetic relatedness, maternal reports of elevated prenatal stress were 
associated with lower infant birth weight and gestational age, and 
increased anxiety and reported antisocial behavior among children 
ranging in age from 4- to 10-years old (Rice et al., 2009). However, 
when current symptoms of maternal anxiety/depression were used 
as an additional covariate, it was found to signiﬁ  cantly mediate the 
association between prenatal stress and increased childhood anxiety 
(Rice et al., 2009). Furthermore, neonates born to mothers with 
prenatal diagnoses of anxiety or depression had increased basal cor-
tisol concentrations if the mother provided insensitive or unrespon-
sive care following birth, but were indistinguishable from neonates 
born to prenatally healthy mothers if provided with more sensitive 
post-natal care (Kaplan et al., 2008a). Thus, the effect of prenatal 
conditions on offspring behavioral outcomes may rely, in part, on 
the post-natal environment that the neonate experiences.
In common with prenatal stress and glucocorticoid exposure, 
neonatal and early childhood environment can have pervasive effects 
on HPA axis functioning and stress responsivity (reviewed in Repetti 
et al., 2002). Though the critical period of limbic development, and 
subsequent HPA axis functioning, is thought to be complete by 
birth in human neonates, over-stimulation of the stress response in 
infants and children can permanently alter stress responsivity and 
risk for disease. For example, young boys of non-supportive parents 
were found to have heightened  sympathetic-adrenomedullary reac-
tivity to laboratory stressors, as measured my increased heart rate 
responses, in comparison to boys of supportive families (Woodall 
and Matthews, 1989). Cardiovascular reactivity also correlates with 
increased left ventricular mass, a major risk factor for chronic heart 
disease (Allen et al., 1997). Furthermore, the biological dysregula-
tions that occur in response to poor family relationships and nega-
tive rearing environments can persist into adulthood; poor parental 
relationships, as   determined by college students rating their early 
family environment, are associated with elevated cortisol responses 
to a laboratory stressor (Luecken, 1998; Pruessner et al., 2004). In 
addition, women with a history of childhood abuse show greater 
responses to staged challenges than women without an abusive 
childhood; responses are further exaggerated among women with 
a history of abuse as a child and current symptoms of anxiety and 
depression (Heim et al., 2000, 2008). Although not directly corre-
lated with altered HPA axis functioning, childhood abuse or house-
hold dysfunction have been associated with increased incidence of 
adult diseases, such as ischemic heart disease, cancer, chronic lung 
disease, skeletal fractures, and liver disease (Felitti et al., 1998). The 
Harvard Mastery of Stress Study, for example, indicated a strong 
correlation between low perceived childhood parental care and 
midlife onset of stress-related illnesses, such as coronary heart dis-
ease, hypertension, duodenal ulceration, and alcoholism (Russek 
and Schwartz, 1997a,b). Furthermore, the incidence of overall dis-
ease was signiﬁ  cantly heightened in individuals who responded 
to stressors with severe anxiety (Russek et al., 1990). Thus, there 
and cell growth. Thus, by decelerating energy metabolism and cell 
growth, the fetus would be able to survive the under-nutritional 
status and conserve glucose and nutrients for the more critical 
process of brain development (Phillips, 1996). However, if such 
mechanisms are semi-permanently programmed in the fetus, then 
the insulin resistance and decreased metabolism could eventually 
lead to type 2 diabetes, obesity, hypertension, and cardiovascular 
disease as the individual ages (reviewed in Sallout and Walker, 2003; 
Barker et al., 2009). Certainly, shortcomings in the fetal program-
ming hypothesis exist; critics have argued since its inception that 
many of the original studies suffered design limitations, such as not 
adequately describing the study population, high subject dropout 
rates, and inadequate control of socioeconomic status (Klebanoff 
et al., 1999). Furthermore, as is often the case when human popu-
lations are examined, neonatal programming studies could not 
effectively establish causation nor thoroughly explore mechanisms 
under consistent conditions. Most of the clinical studies also can 
not distinguish between prenatal and early post-natal inﬂ  uences on 
health. In contrast, animal studies have been crucial for rigorously 
testing hypotheses regarding the mechanisms underlying neonatal 
programming of the HPA axis and adult health outcomes, but are 
limited by the uncertainty as to how closely the neonatal manipu-
lation used in the animal models and the physiological responses 
approximate the human condition. So far, however, the concurrence 
between human and non-human tests of the neonatal program-
ming hypothesis is promising.
Recently, the connection between low birth weight and adult 
cardiovascular health in humans has focused increasingly on 
concomitant changes in HPA axis function (reviewed in Van den 
Bergh and Marcoen, 2004). Exposing the fetus to stress-induced 
concentrations of GCs may permanently alter HPA axis develop-
ment, stress responsivity, life-time glucocorticoid exposure, and 
associated disease risks (Welberg and Seckl, 2001; Rieger et al., 2004; 
Austin et al., 2005). For example, babies that were exposed to dex-
amethasone, a synthetic glucocorticoid, to promote lung growth in 
utero were found to have signiﬁ  cantly higher arterial blood pressure 
at birth than babies of mothers who received the control treatment 
only (Nathanielsz et al., 2003). High arterial blood pressure, in turn, 
has been linked to an increased risk of stroke and heart disease 
in adulthood (MacMahon et al., 1990). Prenatal treatment with 
corticosteroids also has been associated with persistent behavioral 
problems, including increased aggression, attentional deﬁ  cits, and 
cognitive deﬁ  cits (Trautman et al., 1995; French et al., 2004).
There also are indications that fetal stress responsivity can be 
inﬂ  uenced by the mother. For example, fetuses of mothers with 
depression or high levels of anxiety have greater heart rate increases 
as the mother undergoes a psychological stressor than fetuses 
of healthy, low anxiety, non-depressed mothers; fetal heart rate 
responses may serve as a predictor for childhood stress responsivity 
(Monk et al., 2004). Furthermore, high levels of maternal anxi-
ety during critical periods of fetal brain development may result 
in increased susceptibility of the offspring to develop childhood 
affective and behavioral disorders, such as symptoms of attention 
deﬁ  cit hyperactivity disorder, externalization of problems, and 
heightened anxiety in response to stressors (Van den Bergh and 
Marcoen, 2004). Though the impact of early mother-infant interac-
tions cannot be completely separated from genetics and prenatal Frontiers in Behavioral Neuroscience  www.frontiersin.org  December 2009  | Volume 3  |  Article 54  |  4
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in human stroke patients and animal models (Carasso et al., 1981; 
Harmsen et  al., 1990; House et  al., 1990; DeVries et  al., 2001; 
Madrigal et al., 2003; Kivimaki et al., 2008; Surtees et al., 2008; 
Tsutsumi et al., 2009). For example, self and family reports of 
stroke patients indicate that stressful life events often precede the 
onset of stroke, with stroke victims reporting a higher incidence 
of stress occurring days, or even months, prior to stroke onset, in 
comparison to controls (House et al., 1990). Two prospective stud-
ies conﬁ  rm that chronic occupational stress also is associated with 
a substantial increase in stroke risk compared to individuals with 
low reported job stress (Kivimaki et al., 2008; Tsutsumi et al., 2009). 
Similarly, experimental data indicate that rodents that are exposed 
to restraint or social stress prior to experimental stroke develop 
 signiﬁ  cantly larger infarcts than non-stressed cohorts (DeVries 
et al., 2001; Sugo et al., 2002; Madrigal et al., 2003; Caso et al., 2007, 
2008, 2009; McDonald et al., 2008). Furthermore, the treatment of 
mice with a glucocorticoid receptor antagonist immediately prior 
to stress prevents the negative effects of stress on ischemic outcome, 
while injection of exogenous corticosterone mimics the effects of 
stress on infarct size and cognitive function after stroke (Sugo et al., 
2002). Together, the clinical and experimental data suggest that 
exposure to stress or elevated corticosteroids increases both the 
risk for, and the severity of, stroke.
There are equally convincing data concerning the role of 
post-ischemic corticosteroids on outcome. As stated above, several 
clinical studies have documented that elevated post-stroke serum 
concentrations of cortisol are strongly correlated with increased 
physical and mental deﬁ  cits (Murros et al., 1993; Marklund et al., 
2004), and are associated with increased morbidity and mortality 
(Feibel et al., 1977; Olsson, 1990; Marklund et al., 2004). Similarly, 
post-ischemic cortisol concentrations are negatively correlated 
with scores on the Scandinavian Stroke Scale, suggesting that high 
post-stroke cortisol concentrations are associated with exagger-
ated functional and cognitive deﬁ  cits in patients (Christensen 
et al., 2004). Experimental evidence also suggests that elevated 
post-ischemic corticosterone concentrations increase infarct size 
in mice and rats (Rami et al., 1998; DeVries et al., 2001; May et al., 
2002; Neigh et al., 2009). In contrast, adrenalectomy and peri-
ischemic treatment with compounds that decrease circulating 
corticosterone concentrations or glucocorticoid receptor acti-
vation in turn lead to a decrease in neuronal damage following 
both focal and global cerebral ischemia in rodents (Sapolsky and 
Pulsinelli, 1985; Smith-Swintosky et al., 1996; Antonawich et al., 
1999; Risedal et al., 1999; Krugers et al., 2000; Cheng et al., 2009). 
Taken together, these studies suggest that glucocorticoid exposure 
may be a critical determinant of survival and functional outcome 
following cerebral ischemia.
Extensive exploration of the basic mechanisms of GC action 
in the brain after ischemia has only recently begun, and sev-
eral hypotheses have been proposed to explain how stress and 
GC-release exacerbate ischemic cell death. A direct effect of GCs 
on survival in otherwise healthy neurons is possible (Crochemore 
et al., 2005), but probably relatively rare in vivo. It is more likely 
that GCs induce a physiological state that renders neurons more 
susceptible to other mechanisms of cell death following a neuro-
logical insult, such as stroke (Sapolsky, 1985). Indeed, the pattern 
of neuronal death following global cerebral ischemia is similar 
appears to be an emerging association in human literature among 
negative post-natal environment and negative consequences on 
adult HPA axis responsivity and stress-related disease.
Though the human correlational data provide convincing 
 evidence for the relationship among fetal programming of the HPA 
axis, early parental care, and adult health, it is not possible to estab-
lish a causal relationships among early life experiences, HPA axis 
dysregulation, and compromised health from the clinical datasets; 
it is in this regard that rodent studies on the topic of prenatal and 
post-natal programming of the HPA axis are critically important 
(reviewed in Weinstock, 2008; Champagne, 2009). Studies in rats 
have established that one of the molecular mechanisms underly-
ing perinatal programming of the HPA axis involves epigenetic 
changes in glucocorticoid receptor expression due to changes in 
histone acetlyation and DNA demethylation (reviewed in Weaver, 
2009). These ﬁ  ndings suggest that maternal care can produce semi-
permanent changes in gene expression in brain regions vital to 
stress responsivity, thereby providing a potential mechanism for 
fetal and neonatal programming of adult, stress-induced disease 
in humans.
ESTABLISHING A CAUSAL RELATIONSHIP BETWEEN HPA 
AXIS ACTIVITY AND CEREBRAL ISCHEMIA
Cerebral ischemia is the loss of blood ﬂ  ow and oxygen to cells in 
the brain. When the reduction in blood ﬂ  ow occurs throughout the 
entire brain, for example during cardiac arrest, it is termed global 
cerebral ischemia. In contrast, if only a region of the brain experi-
ences reduced blood ﬂ  ow, for example during stroke, it is termed 
focal ischemia. At the cellular level, ischemia initiates neuronal 
death pathways and immunological trafﬁ  cking (Doyle et al., 2008; 
Ribe et al., 2008; Amantea et al., 2009). Clinical and experimental 
data suggest that the HPA axis may have important inﬂ  uences on 
these pathophysiological responses to ischemia.
Activation of the HPA axis is among the ﬁ  rst, easily measur-
able, physiological responses to cerebral ischemia (Fassbender 
et al., 1994; Johansson et al., 1997; Slowik et al., 2002). There is 
a   sustained surge in GCs that persists for days after the ischemic 
attack. Though post-ischemic GC-release was initially postulated to 
be beneﬁ  cial (i.e. by reducing edema), the functional signiﬁ  cance of 
this response remains largely speculative and, in fact, may adversely 
affect neuronal survival (Anne et al., 2007). Until recently, treat-
ment of stroke patients with exogenous GCs upon admission to the 
hospital was standard protocol, but it is no longer recommended 
in light of the relationship between elevated endogenous cortisol 
and poor stroke outcome, and the potential for GCs to alter other 
physiological processes, such as glycemic balance, that are associated 
with poor stroke prognosis (Gomes et al., 2005). Indeed, among 
stroke patients, high acute phase endogenous cortisol is associated 
with increased infarct volume, greater functional disability, and 
increased mortality (Murros et al., 1993; Fassbender et al., 1994; 
Christensen et al., 2004; Marklund et al., 2004; Anne et al., 2007). 
Thus, environmental and genetic factors that modify HPA axis 
activity could, in turn, affect susceptibility to ischemic disease.
The literature provides a convincing association between stress 
and stroke outcome, with evidence presented from both   clinical 
and experimental studies (Table 1). Pre-ischemic stress and 
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to the general pattern of GC receptor concentration; cell death 
is greatest in the hippocampus, where GR are most abundant, 
despite the fact that the entire brain is experiencing a similar 
level of ischemia (Sapolsky, 1985). However, exposure to stress 
or exogenous GCs also increases cell death in brain regions with 
low to moderate GR concentration, such as the cortex, striatum 
and caudate putamen, so either GR expression is low, but suf-
ﬁ  cient to promote cell death in neurons already compromised 
by ischemia, or GC may be acting via multiple mechanism to 
compromise neuronal survival (Sapolsky and Pulsinelli, 1985; 
Sapolsky, 1999).
Three of the most thoroughly established mechanisms of 
GC-mediated ischemic cell death involve increased glutamater-
gic excitotoxicity, suppression of bcl-2 expression, and increased 
neuroinﬂ  ammation. Glutamate accumulates in the core infarct 
region during ischemia (Sapolsky, 2001; Smith, 2004), then spreads 
within hours to tissue surrounding the infarct (Woitzik et al., 2009). 
The role of glutamate in ischemic cell death is conﬁ  rmed by sev-
eral studies that show glutamate receptor antagonists (Rothman, 
1984; Simon et al., 1984; Kundrotiene et al., 2004; cf. Hoyte et al., 
2004) and lesions of glutamatergic inputs (Johansen et al., 1986; 
Onodera et  al., 1986; Kimura and Saji, 1997) reduce ischemic 
Table 1 | Summary of supportive literature indicating stress and glucocorticoid activity inﬂ  uence stroke outcome.
SUGGESTIVE THAT STRESS INCREASES STROKE RISK AND ELEVATED GLUCOCORTICOIDS MAY BE DETRIMENTAL
Marklund et al. (2004)  Human  Hypercortisolism is associated with cognitive dysfunction after stroke, while
    both unusually high and unusually low circulating cortisol levels are associated
    with increased mortality after stroke.
Gomes et al. (2005)  Human  Review of published clinical studies using glucocorticoid administration to treat
    neurological disorders; conclude that it is not beneﬁ  cial in treatment of acute stroke.
Anne et al. (2007)  Human  High acute phase cortisol concentrations in ﬁ  rst-ever stroke patients predict
    long-term mortality in a multivariate analysis.
Kivimaki et al. (2008)  Human  A prospective cohort study in which individuals who reported job strain had a 1.76
    times higher age-adjusted risk of incident ischemic disease than those without job strain.
Surtees et al. (2008)  Human  A prospective study in which individuals with lower scores on the Mental
    Health Inventory (MHI-5; suggesting mental distress) had an 11% increased risk of stroke.
Tsutsumi et al. (2009)  Human  A prospective study of Japenese men in which those with job stress
    (high job demands and low job control) have a 2-fold increase in stroke risk.
SUGGESTIVE THAT STRESS AND ELEVATED GLUCOCORTICOIDS EXACERBATE EXPERIMENTAL CEREBRAL ISCHEMIA
DeVries et al. (2001)  Mouse (focal ischemia)  Chronic social stress suppresses post-ischemic bcl-2 gene expression; infarct
    size is correlated with post-ischemic corticosteroid concentrations. 
Sugo et al. (2002)  Mouse (focal ischemia)  Exposure to chronic social stress or treatment with exogenous corticosterone
    before stroke increases resulting infarct size and cognitive deﬁ  cits. Treatment
    with a glucocorticoid receptor antagonist prevents the effects of social stress
    on infarct volume and cognitive performance.
Madrigal et al. (2003)  Rat (focal ischemia)  One hour of restraint daily for 7 days increases infarct size while 6 h of
    restraint daily for 21 days decreases infarct size.
Caso et al. (2006)  Rat (focal ischemia)  Restraint stress increases post-stroke TNF-α and TNF receptor 1 expression. 
    Pharmacological blockade of TNF-α decreases stroke-induced infarct size and
    measures of oxidative stress.
Caso et al. (2007)  Rat (focal ischemia)  Exposure to restraint stress prior to stroke increases post-ischemic IL -1β in
    the cerebral cortex and infarct size. Treatment with an IL -1β antibody reduces
    ischemia-induced infarct size, neurological deﬁ  cits and behavioral deﬁ  cits.
McDonald et al. (2008)  Rat (sub-threshold focal ischemia)  Infusion of a low dose of endothelin-1 into the hippocampus had no effect on
    non-stressed rats. By contrast, the same dose resulted in neuronal death
    and cognitive deﬁ  cits among stressed rats.
Caso et al. (2008)  Mouse (focal ischemia)  Restraint stress increases post-ischemic neuroinﬂ  ammation and infarct size in
    wild-type mice, but not transgenic mice that lack toll-like receptor-4 expression. 
Neigh et al. (2009)  Mouse (global ischemia)  Exposure to restraint stress prior to cardiac arrest/CPR increases ischemia-induced
    microglial activation and neuronal damage. 
SUGGESTIVE OF THE POTENTIAL FOR NEONATAL PROGRAMMING OF NEURONAL RESPONSES TO INJURY
Horvath et al. (2004)  Rat (NMDA infusion)  Brief maternal separation during the ﬁ  rst weeks of life signiﬁ  cantly increases 
    adult neurodegeneration following infusion with N-methyl-D-aspartate (NMDA).
Craft et al. (2006)  Mouse (focal ischemia)  Brief maternal separation during the ﬁ  rst 2 weeks of life decreases the
    corticosteroid response to experimental stroke in adulthood, but increases
   post-stroke  pro-inﬂ  ammatory cytokine expression, edema, infarct volume, and mortality.Frontiers in Behavioral Neuroscience  www.frontiersin.org  December 2009  | Volume 3  |  Article 54  |  6
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injury. Ischemia raises extracellular glutamate concentrations to 
toxic levels (Globus et al., 1988; Arundine and Tymianski, 2004) 
which are further ampliﬁ  ed by an increase in circulating GCs. For 
example, stress levels of corticosterone drastically increase gluta-
mate accumulation (3–4 fold increase over basal concentrations) 
with or without a coincident neurological insult (Stein-Behrens 
et al., 1992); thus, the elevation of GCs can exacerbate glutamatergic 
excitotoxicity following stroke. Furthermore, the ischemia-induced 
deﬁ  cits in glutamate transporter function are exaggerated by stress; 
glutamate transport is impaired by the further depletion of ATP 
supply, and transporter gene expression is altered in neuronal tis-
sue (Madrigal et al., 2003). The combination of a stress-induced 
increase in extracellular glutamate and decrease in glutamate trans-
port has the potential to escalate glutamate’s neurotoxic effect dur-
ing cerebral ischemia.
Stress-released hormones also have a profound effect on expres-
sion of the bcl-2 family of genes, which are important regulators of 
cell death (Merry and Korsmeyer, 1997). The bcl-2 family consists 
of both pro-apoptotic proteins, such as bax, and anti-apoptotic 
proteins, such as bcl-2. Over-expression of bcl-2 has been found 
to protect against both apoptosis and necrosis following ischemia 
(Linnik et al., 1995; Alkayed et al., 2001; reviewed in Kuschinsky 
and Gillardon, 2000). It has been proposed that bcl-2 protects 
neurons from apoptosis through regulation of intracellular CA2+ 
concentrations (McConkey and Orrenius, 1997). Though the exact 
mechanism of bcl-2 neuroprotection remains to be determined, 
there is a large body of experimental literature demonstrating 
how its expression can be altered. For example, socially stressed 
mice have larger infarcts than controls due to GC-mediated sup-
pression of stroke-induced bcl-2 expression (DeVries et al., 2001). 
Furthermore, transgenic mice that have enhanced bcl-2 expres-
sion are protected from the deleterious effects of stress on stroke 
outcome (DeVries et al., 2001). Aged animals may be particularly 
sensitive to a stress-induced shift in the ratio of bax:bcl-2 expres-
sion, that would increase the apopototic vulnerability of neurons 
(Almeida et al., 2000).
Neuroinﬂ  ammation is a third mechanism through which stress 
appears to modify ischemic outcome. A growing body of litera-
ture has provided evidence that brain injury is also accompanied 
by marked inﬂ  ammatory reaction, characterized by inﬁ  ltration 
of granulocytes, monocytes and macrophages into the respec-
tive brain parenchyma (Perry and Gordon, 1991), activation of 
microglia and astrocytes, and expression of pro-inﬂ  ammatory 
cytokines, adhesion molecules and other inﬂ  ammatory mediators 
(Feuerstein et al., 1998; Dirnagl et al., 1999; Dinkel et al., 2003). 
Cytokines, in particular, have a marked upregulation following 
stroke (reviewed in DeGraba, 1998). Experimental models of stroke 
have demonstrated increased concentrations of interleukin mRNA 
in ischemic tissue, including IL-1α, IL-1β, IL-1ra, and IL-6 (Zhai 
et al., 1997; Hill et al., 1999; Legos et al., 2000). Similar evidence 
exists in clinical studies, with increased interleukin concentrations 
reported in both   cerebrospinal ﬂ  uid (CSF) and serum following 
stroke (Tarkowski et al., 1995; Ferrarese et al., 1999; Rodriguez-
Yanez and Castillo, 2008). Furthermore, post-ischemic concentra-
tions of pro-inﬂ  ammatory cytokines are positively correlated with 
infarct size (Tarkowski et al., 1995; Yang et al., 1999; Vila et al., 2000; 
Boutin et al., 2001; Touzani et al., 2002; Allan et al., 2005), whereas 
over-expression of, or  treatment with, anti- inﬂ  ammatory cytokines 
(i.e. IL-1ra; Yang et al., 1999; Emsley et al., 2005) or growth fac-
tor (i.e. neuregulin-1β; Xu et al., 2005) that down-regulate pro-
 inﬂ   ammatory cytokine expression result in reduced ischemic 
injury. Thus, cytokine regulation is vital to ischemic outcome, and 
is becoming a key target for therapeutic and preventive treatment 
of stroke (Jordan et al., 2008).
The inﬂ  ammatory cytokine cascade that occurs in the brain fol-
lowing stroke has been most thoroughly characterized in rats and 
mice. The primary response to ischemia is mediated by IL-1β and 
TNF-α, both of which orchestrate the migration of  inﬂ  ammatory 
cells to the site of ischemic injury (DeGraba, 1998; Zhang and 
Stanimirovic, 2002). IL-1β and TNF-α are detected post-stroke 
as early as 1–3 h and 3–6 h, respectively. Though both reach their 
peak concentration at 12 h, the actual functional outcome of 
IL-1β protein expression does not peak until 72 h (Legos et al., 
2000). At approximately 6-h post-ischemia, just prior to the down-
 regulation of IL-1β and TNF-α, a surge in the expression of IL-10 is 
observed. IL-10 is an anti-inﬂ  ammatory cytokine that may control 
the duration and extent of the inﬂ  ammatory response to ischemia 
by inhibiting the production of TNF-α (Zhai et al., 1997). The 
secondary response involves IL-6 and IL-8 (DeGraba, 1998). The 
large inﬂ  ux of inﬂ  ammatory cells initiated by IL-1β and TNF-α 
may be responsible for the synthesis of IL-6 (Legos et al., 2000), 
which peaks at 24-h post-stroke. IL-6 has recently been found 
to have important anti-inﬂ  ammatory and immunosuppressive 
effects after stroke (Dziedzic et al., 2002; Karelina et al., 2009). 
IL-6 regulates concentrations of pro-inﬂ  ammatory cytokines via a 
negative feedback function initiated by its upregulation by TNF-α 
(DeGraba, 1998). IL-8, on the other hand, remains elevated for 
7 days following stroke and is thought to have neurodegenerative 
effects; indeed, a decrease in infarct size and edema are observed 
when IL-8 is neutralized or its receptors blocked during cerebral 
ischemia (Villa et al., 2007). Thus, the careful balance of pro- and 
anti-inﬂ  ammatory cytokines can have critical implications in neu-
ronal survival following stroke.
Though the HPA axis and immune system both have signiﬁ  cant 
roles in the pathophysiology of stroke, they are often considered 
as separate entities rather than interacting physiological processes. 
Indeed, GCs have often been used to treat inﬂ  ammatory responses 
within the central nervous system, such as to suppress tumor-
induced edema in the brain, to treat viral or bacterial encephalitis, 
and to improve acute onset of multiple sclerosis (Salaki et al., 1984; 
Barnes and Adcock, 1993; Coyle, 1999; Filippini et al., 2000); how-
ever, there is no evidence that exogenous GCs improve clinical stroke 
outcome by suppressing inﬂ  ammation (Gomes et al., 2005). Dose 
may be important in determining whether exogenous GCs have 
an inﬂ  ammatory or anti-inﬂ  ammatory effect in the brain during 
certain disease processes; for example, in primary hippocampal cul-
tures, low doses of corticosteroids suppress the expression of inﬂ  am-
matory cytokines while, higher doses of corticosteroids result in a 
signiﬁ  cant increase in IL-1β and TNF-α expression (MacPherson 
et al., 2005). In vivo, kainic acid induces more TNF-α and IL-1β 
expression and neuronal damage if the rats have been chronically 
treated with GCs at a level that approximates stress (Dinkel et al., 
2003). Likewise, peri-ischemic exposure to stress or exogenous glu-
corticoids increases neuroinﬂ  ammation, including the expression Frontiers in Behavioral Neuroscience  www.frontiersin.org  December 2009  | Volume 3  |  Article 54  |  7
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of pro-inﬂ  ammatory cytokines such as TNF-α and IL-1β that are 
associated with exacerbation of ischemia-induced neuronal damage 
(Caso et al., 2006, 2007, 2008, 2009). Thus, the experimental studies 
suggest that there is a causal relationship between elevated corticos-
teroids and increased neuroinﬂ  ammation after cerebral ischemia.
EFFECTS OF EARLY PROGRAMMING OF THE HPA AXIS ON 
EXPERIMENTAL STROKE
As reviewed above, the HPA axis is an important modulator of 
ischemic outcome. In light of the association between peri-ischemic 
glucocorticoid exposure and stroke outcome, one might logically 
predict that vulnerability to stroke would be increased by perina-
tal manipulations that increase exposure to GCs and decreased by 
perinatal manipulations that decrease exposure to GCs. However, 
a review of the literature concerning neonatal manipulations and 
their effects on immune function suggests that the relationship 
may not be so simple; one consequence of chronically dampened 
HPA axis reactivity may be increased susceptibility to inﬂ  amma-
tion and inﬂ  ammatory disorders (Shanks and Lightman, 2001), 
which in the case of stroke could be lethal. To examine the effects 
of early programming of the HPA axis on stroke, we used the brief 
maternal separation (BMS)/handling paradigm that has been most 
thoroughly characterized in rats, but successfully applied to sev-
eral species with similar results, including mice (Parﬁ  tt et al., 2004). 
Brief periods of maternal separation (approximately 15 min per 
day) during the ﬁ  rst several weeks of development leads to increased 
expression of GR in the hippocampus and frontal cortex (Meaney 
et al., 1985; O’Donnell et al., 1994; McCormick et al., 2000; Ladd 
et al., 2004) and dampened physiological and behavioral responses 
to stressors (Meaney et al., 1991b; Liu et al., 1997; Vallee et al., 1997; 
Francis et al., 1999), presumably due to increased sensitivity of the 
HPA axis to negative feedback regulation (Meaney et al., 1989). This 
neonatal programming of the HPA axis also is protective against 
the decline in hippocampal neural density and cognitive function 
that is typically observed among aged rats (Meaney et al., 1988, 
1991a). As predicted based on these studies, adult mice that were 
exposed to BMS as neonates had signiﬁ  cantly lower corticosteroid 
responses to the induction of experimental stroke than mice that 
had not been manipulated during development (Craft et al., 2006). 
However, despite the lower endogenous corticosteroid response dur-
ing ischemia, BMS mice sustained signiﬁ  cantly more stroke-induced 
neuroinﬂ  ammation, neuronal damage and behavioral deﬁ  cits than 
mice that were raised under typical colony conditions (Craft et al., 
2006). Interestingly, 24 h after stroke the size of the core infarct 
was similar between the BMS and control mice, and while infarct 
size remained steady among controls over the subsequent 48 h, 
it nearly tripled among the BMS mice. Furthermore, if the mice 
were adrenalectomized prior to stroke and implanted with pellets 
that produced circulating corticosterone concentrations that were 
similar to those observed among intact mice 24 h after stroke, then 
the same infarct pattern emerged. In contrast, if the adrenalect-
omized mice were implanted with pellets that produced relatively 
low circulating corticosterone concentrations (half the typical 
post-stroke concentration), then there was no difference in infarct 
volume between BMS and control mice at 72 h (Craft et al., 2006). 
Together these data suggest that the BMS mice were more sensitive 
than unmanipulated mice to the deleterious effects of persistently 
high corticosterone concentrations following stroke, possibly due 
to increased GR expression among BMS mice (reviewed above). 
In addition, the increase in edema, IL-1β expression, and TNF-α 
expression also may have contributed to the large infarcts among 
the BMS mice. Interestingly, BMS also is associated with increased 
N-methyl-D-aspartate (NMDA)-induced neurodegeneration in 
otherwise healthy rats (Horvath et al., 2004), and it is possible that 
alterations in glutamate signaling among BMS mice could have con-
tributed to the exacerbation of neuronal damage after experimental 
stoke, as well. Thus, there are several mechanisms through which 
BMS could be exacerbating stroke outcome, including increased sen-
sitivity to GR-mediated effects on neuronal damage during a neuro-
logical insult, increased neuroinﬂ  ammation, and altered glutamate 
signaling. Whether these are independent or interrelated pathways 
affecting stroke outcome remains to be determined.
SUMMARY
Recent clinical data suggest that prenatal and early post-natal pro-
gramming of the HPA axis may inﬂ  uence vulnerability to an array 
of stress-related health conditions, including cerebrovascular dis-
ease. Indeed, the HPA axis plays an important role in determining 
stroke outcome. Exposure to stress appears to increase both the 
incidence and severity of stroke, and activation of the HPA axis 
is among the ﬁ  rst, easily measurable, physiological responses to 
stroke. Peri-ischemic glucocorticoid concentrations are positively 
correlated with stroke severity in both humans and rodents, and 
converging evidence from several labs using different species and 
experimental stroke models provides strong support for a causal 
relationship between elevated per-ischemic glucocorticoid con-
centrations and increased neuronal death following ischemia. A 
large body of work in rats and mice suggest that it is also possible 
to program the HPA axis in such a way as to decrease life-time 
exposure to glucocorticoids, which in turn can lead to improved 
neurological and cognitive aging. By pairing these data with the 
prospective clinical studies reporting increased risk of stroke among 
individuals who report elevated personal and work-related stress, 
one could propose that a reduction in stress responsivity and life-
time exposure to glucocorticoids could lead to reduced incidence of 
stroke. However, when we used a well-developed handling and brief 
maternal separation model in mice to examine how reduced HPA 
activity affected adult ischemic outcome, we were surprised by 
the results. The neonatally manipulated mice had a reduced ini-
tial corticosteroid response to stroke, as expected, but ultimately 
developed more neuroinﬂ  ammation, edema, and neuronal dam-
age than unmanipulated cohorts. Also, post-stroke survival was 
reduced in the neonatally manipulated mice. From these data we 
surmise that one potential cost associated with more efﬁ  cient day 
to day regulation of the HPA axis may be increased susceptibility 
to neuroinﬂ  ammation and neurological damage if a stroke occurs. 
An independent study in rats conﬁ  rms that neonatal handling also 
increases susceptibility to NMDA-induced neuronal damage. Thus, 
increased neuronal sensitivity to certain types of injury could be 
a cost associated with neonatal dampening of HPA axis activity. 
Given the importance of the HPA axis in the regulation of health 
and disease states, it seems reasonable to expect that any long-term 
modulation of the HPA axis is likely to be associated with both 
beneﬁ  ts and potential risks.Frontiers in Behavioral Neuroscience  www.frontiersin.org  December 2009  | Volume 3  |  Article 54  |  8
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